Swing Trading Strategy Report #29

2017-09-06T09:15:00-04:00September 6, 2017|

My Swing Trading Approach North Korea overnight risk creates some pause for this market and the likelihood of some kind of boiling point being reached as a result of their provocations.  As a result, it is difficult to get confidently long on this market, and best practice suggests playing both [...]

Swing Trading Strategy Report #27

2017-09-01T09:07:00-04:00September 1, 2017|

My Swing Trading Approach The bounce of late has been a hard bounce, and more than a dead cat bounce. This bounce should be respected and played. The biggest risk to consider remains North Korea.  Indicators […]

Swing Trading Strategy Report #6

2017-08-03T09:00:00-04:00August 3, 2017|

My Swing Trading Approach We have the S&P 500 stuck in a 10-day trading range. I am keeping a neutral portfolio until it can determine a direction coming out of the range. At that point I’ll either get more bearish or more bullish, depending on the direction that the market [...]

Stock Market Today: Entering the Phantom Zone

2017-02-28T09:03:35-05:00February 28, 2017|

My Trading Journal for the Stock Market Today:  I'm pretty sure we are at that point where, "how many days can the Dow push higher", has become irrelevant. Lets just admit it, we are in the Phantom Zone at this point. We can decline 1% today is probably less likely than [...]

Trading ETFs Long and Short and The Best ETFs to Buy

2024-06-01T17:33:59-04:00January 24, 2017|

Finding the Best ETFs for Trading Exchange Traded Funds (ETFs) are all the rage these days. Traders are always on the hunt for the latest and greatest ETFs and what is the best ETF to trade on a day-to-day basis. ETFs come in all shapes and sizes and each day [...]

Where is Biotech Going From Here?

2016-06-07T14:49:26-04:00June 7, 2016|

Valeant Pharmaceuticals (VRX) is down 14%, Biogen (BIIB) is down 12.3%. I guess it goes without saying that Bill Ackman is having another lousy day. The weakness in biotech is keeping the Nasdaq from experiencing a rally of any sorts today, despite the Dow, SPX, Rut all on solid ground.  [...]

This Is Why you Don’t Trade Biotechs

2016-04-26T13:33:14-04:00April 26, 2016|

This isn’t uncommon – I swear I talk about not trading biotechs every single week because some stock gets killed by the FDA. That is because unless you are an expert in the field (which I am not and you probably aren’t either) the risk you take trading biotechs are [...]

Go to Top